Pharmaceuticals

Addex Pharmaceuticals SA
Chemin des Aulx 12
1228
Plan-les-Ouates
1228 Plan-les-Ouates
Auf Karte anzeigen
022 884 15 55
022 884 15 56
info@addexpharma.com
www.addexpharma.com
Öffnungszeiten
MO: 08:00 - 17:00
Firmenbeschrieb
Addex Pharmaceuticals is a pharmaceutical company committed to the discovery and development of novel therapeutic compounds for the treatment of central nervous system (CNS) disorders.Addex has a fully integrated preclinical and clinical development capability and is focused on novel targets. The company has proprietary compounds in pre-clinical and clinical development for the treatment of major CNS indications including Alzheimer’s disease, schizophrenia, anxiety, depression, pain, nicotine dependence and Parkinson’s disease.The majority of Addex’ management is from large pharmaceutical companies, which has driven the rapid focusing of activities on drug development. Today Addex is operating with the same quality standards as the large pharma and this has been recognized by its recent collaboration with Johnson and Johnson.Gründungsjahr
2001
Anzahl Mitarbeiter
60
Marktleistungen
-
ADX10061
ADX10061 is a D1 selective antagonist which will enter a Phase II trial for smoking cessation in the US.
-
ADX10059
ADX10059 is a potent negative allosteric modulator of mGluR5 for the treatment of anxiety and which entered preclinical development.
Eintrag erstellt: 07.09.2005, Letzte Änderung: 03.10.2006
